Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Guilty as charged: B-RAF is a human oncogene.

Mathew J Garnett1, Richard Marais

  • 1Signal Transduction Team, Cancer Research UK Centre for Cell and Molecular Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, United Kingdom.

Cancer Cell
|October 19, 2004
PubMed
Summary

Recent findings reveal BRAF (B-RAF) is a frequently mutated oncogene in human cancers. This review summarizes our understanding of BRAF

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The PRECISE European initiative for cancer-vulnerability mapping and prediction.

Nature genetics·2026
Same author

Mutational signatures of environmental carcinogens in human tissue organoids revealed by duplex sequencing.

Cell reports·2026
Same author

Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial.

Nature communications·2026
Same author

BEstimate: a computational tool for the design and interpretation of CRISPR base editing experiments.

Genome biology·2026
Same author

Multiplexed TrAEL-seq captures DNA replication dynamics in mammalian cells.

Nucleic acids research·2026
Same author

Genetic interactions, synthetic lethality and complexity in cancer vulnerability mapping-Insights and perspectives from the 2nd EuroDepMap symposium.

FEBS letters·2026

Area of Science:

  • Cellular signaling pathways
  • Molecular oncology
  • Cancer genetics

Background:

  • RAF proteins are key regulators of cellular responses to extracellular signals.
  • Despite extensive research, the oncogenic role of the B-RAF isoform is a recent discovery.
  • High-frequency mutations in B-RAF are observed in various human cancers.

Purpose of the Study:

  • To review the recent advancements in understanding B-RAF.
  • To discuss the role of B-RAF as an oncogene in human cancer.
  • To highlight the significance of B-RAF mutations in cancer development.

Main Methods:

  • Literature review of studies on RAF proteins and B-RAF.
  • Analysis of research on B-RAF mutations and their frequency in cancer.
  • Synthesis of current knowledge on B-RAF's function as an oncogene.

Main Results:

  • B-RAF is a significant oncogene implicated in human cancers.
  • Mutations in B-RAF occur frequently across diverse cancer types.
  • Understanding B-RAF's oncogenic role has progressed rapidly.

Conclusions:

  • B-RAF is a critical player in cancer development due to its frequent mutations.
  • Continued research into B-RAF is essential for targeted cancer therapies.
  • The discovery of B-RAF's oncogenic nature has opened new avenues in oncology.

Related Experiment Videos